Literature DB >> 20046540

Sildenafil- and tadalafil-associated optic neuropathy: implications for men after prostate cancer treatment.

June M McKoy1, Carlos R Bolden, Athena Samaras, Dennis W Raisch, Kevin Chandler, Charles L Bennett.   

Abstract

Entities:  

Year:  2009        PMID: 20046540      PMCID: PMC2800378          DOI: 10.1016/s1548-5315(11)70214-5

Source DB:  PubMed          Journal:  Community Oncol        ISSN: 1548-5315


× No keyword cloud information.
  4 in total

1.  Recurrent visual field defect and ischemic optic neuropathy associated with tadalafil rechallenge.

Authors:  Kathryn Bollinger; Michael S Lee
Journal:  Arch Ophthalmol       Date:  2005-03

2.  Sildenafil-associated nonarteritic anterior ischemic optic neuropathy.

Authors:  Howard D Pomeranz; Kyle H Smith; William M Hart; Robert A Egan
Journal:  Ophthalmology       Date:  2002-03       Impact factor: 12.079

3.  Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (viagra): a report of seven new cases.

Authors:  Howard D Pomeranz; Abdhish R Bhavsar
Journal:  J Neuroophthalmol       Date:  2005-03       Impact factor: 3.042

Review 4.  Molecular pharmacotherapeutic targeting of PDE5 for preservation of penile health.

Authors:  Arthur L Burnett
Journal:  J Androl       Date:  2007-10-17
  4 in total
  1 in total

Review 1.  Are we pharmacovigilant enough in ophthalmic practice?

Authors:  Ashok Dubey; Shailendra S Handu
Journal:  Indian J Ophthalmol       Date:  2013-05       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.